113 related articles for article (PubMed ID: 24051869)
1. Incidence of brain metastases after trimodality therapy in patients with esophageal or gastroesophageal cancer: implications for screening and surveillance.
Wadhwa R; Taketa T; Correa AM; Sudo K; Campagna MC; Blum MA; Komaki R; Skinner H; Lee JH; Bhutani MS; Weston B; Maru DM; Rice DC; Swisher S; Hofstetter WL; Ajani JA
Oncology; 2013; 85(4):204-7. PubMed ID: 24051869
[TBL] [Abstract][Full Text] [Related]
2. Analysis of pathological complete response rates with paclitaxel-based regimens in trimodality therapy for esophageal cancer.
Boggs DH; Tarabolous C; Morris CG; Hanna A; Burrows W; Horiba N; Suntharalingam M
Dis Esophagus; 2015 Oct; 28(7):619-25. PubMed ID: 24863682
[TBL] [Abstract][Full Text] [Related]
3. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.
Hategan M; Cook N; Prewett S; Hindmarsh A; Qian W; Gilligan D
Dis Esophagus; 2015 Oct; 28(7):612-8. PubMed ID: 24863560
[TBL] [Abstract][Full Text] [Related]
4. Brain metastases from esophageal cancer: a phenomenon of adjuvant therapy?
Rice TW; Khuntia D; Rybicki LA; Adelstein DJ; Vogelbaum MA; Mason DP; Murthy SC; Blackstone EH
Ann Thorac Surg; 2006 Dec; 82(6):2042-9, 2049.e1-2. PubMed ID: 17126108
[TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
6. Incidence of brain metastasis from esophageal cancer.
Welch G; Ross HJ; Patel NP; Jaroszewski DE; Fleischer DE; Rule WG; Paripati HR; Ramirez FC; Ashman JB
Dis Esophagus; 2017 Sep; 30(9):1-6. PubMed ID: 28859365
[TBL] [Abstract][Full Text] [Related]
7. Management of late distant metastases after trimodality therapy for esophageal cancer.
Mao YS; Suntharalingam M; Krasna MJ
Ann Thorac Surg; 2003 Nov; 76(5):1742-3. PubMed ID: 14602333
[TBL] [Abstract][Full Text] [Related]
8. Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies.
Sudo K; Taketa T; Correa AM; Campagna MC; Wadhwa R; Blum MA; Komaki R; Lee JH; Bhutani MS; Weston B; Skinner HD; Maru DM; Rice DC; Swisher SG; Hofstetter WL; Ajani JA
J Clin Oncol; 2013 Dec; 31(34):4306-10. PubMed ID: 24145339
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma.
Gerber N; Ilson DH; Wu AJ; Janjigian YY; Kelsen DP; Zheng J; Zhang Z; Bains MS; Rizk N; Rusch VW; Goodman KA
Dis Esophagus; 2014 Apr; 27(3):235-41. PubMed ID: 23796070
[TBL] [Abstract][Full Text] [Related]
10. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
[TBL] [Abstract][Full Text] [Related]
11. Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients.
Lopez A; Harada K; Chen HC; Bhutani MS; Weston B; Lee JH; Maru DM; Chin FW; Rogers JE; Thomas I; Amlashi FG; Blum-Murphy MA; Rice DC; Zhao M; Hofstetter WL; Nguyen Q; Ajani JA
Medicine (Baltimore); 2020 Feb; 99(9):e19295. PubMed ID: 32118743
[TBL] [Abstract][Full Text] [Related]
12. Resectable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy.
Chidel MA; Rice TW; Adelstein DJ; Kupelian PA; Suh JH; Becker M
Radiology; 1999 Oct; 213(1):67-72. PubMed ID: 10540642
[TBL] [Abstract][Full Text] [Related]
13. Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting.
Murphy CC; Hofstetter WL; Correa AM; Ajani JA; Komaki RU; Swisher SG
Dis Esophagus; 2013; 26(7):708-15. PubMed ID: 23350713
[TBL] [Abstract][Full Text] [Related]
14. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
15. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.
Shridhar R; Freilich J; Hoffe SE; Almhanna K; Fulp WJ; Yue B; Karl RC; Meredith K
Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492
[TBL] [Abstract][Full Text] [Related]
16. The impact of neoadjuvant chemoradiotherapy on perioperative outcomes, tumor pathology, and survival in clinical stage II and III esophageal cancer.
Markar SR; Bodnar A; Rosales J; Song G; Low DE
Ann Surg Oncol; 2013 Nov; 20(12):3935-41. PubMed ID: 23892525
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chemoradiation therapy does not improve early survival after esophagectomy for patients with clinical stage III adenocarcinoma of the esophagus.
Donington JS; Miller DL; Allen MS; Deschamps C; Nichols FC; Pairolero PC
Ann Thorac Surg; 2004 Apr; 77(4):1193-8; discussion 1198-9. PubMed ID: 15063233
[TBL] [Abstract][Full Text] [Related]
18. Nonsurgical management of esophageal adenocarcinoma.
Gujral DM; Hawkins MA; Leonulli BG; Ashley S; Chau I; Cunningham D; Tait D
Clin Colorectal Cancer; 2011 Sep; 10(3):165-70. PubMed ID: 21855037
[TBL] [Abstract][Full Text] [Related]
19. Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction.
Ajani JA; Correa AM; Walsh GL; Komaki R; Lee JH; Vaporciyan AA; Rice DC; Yao JC; Maru DM; Hofstetter WL; Phan AT; Swisher SG
Cancer; 2010 Apr; 116(7):1656-63. PubMed ID: 20143431
[TBL] [Abstract][Full Text] [Related]
20. Incidence of brain metastasis in patients with esophageal carcinoma.
Smith RS; Miller RC
World J Gastroenterol; 2011 May; 17(19):2407-10. PubMed ID: 21633640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
